Bristol Myers Squibb Pharma EEIG
- B03 - Preparados antianémicos
- REBLOZYL powder and solvent for solution for injection 25 mg
- REBLOZYL powder and solvent for solution for injection 75 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- KARVEA tablet 150 mg
- KARVEA tablet 300 mg
- KARVEA tablet 75 mg
- J05 - Antivirales de uso sistémico
- EVOTAZ film-coated tablet 300 mg+150 mg
- REYATAZ capsule, hard 300 mg
- REYATAZ capsule, hard 50 mg
- REYATAZ oral powder 50 mg
- SUSTIVA capsule, hard 100 mg
- SUSTIVA capsule, hard 200 mg
- SUSTIVA capsule, hard 50 mg
- SUSTIVA film-coated tablet 300 mg
- SUSTIVA film-coated tablet 600 mg
- SUSTIVA oral solution 30 mg/ml
- ZERIT prolonged-release tablet
- L01 - Antineoplásicos
- EMPLICITI lyophilisate for solution for infusion 300 mg
- EMPLICITI lyophilisate for solution for infusion 400 mg
- OPDIVO concentrate for solution for infusion 10 mg/ml
- SPRYCEL film-coated tablet 100 mg
- SPRYCEL film-coated tablet 140 mg
- SPRYCEL film-coated tablet 20 mg
- SPRYCEL film-coated tablet 50 mg
- SPRYCEL film-coated tablet 70 mg
- SPRYCEL film-coated tablet 80 mg
- SPRYCEL powder for oral suspension 10 mg/ml
- VIDAZA powder for suspension for injection 25 mg/ml
- YERVOY concentrate for solution for infusion 5 mg/ml
- L04 - Inmunosupresores
- IMNOVID capsule, hard 1 mg
- IMNOVID capsule, hard 2 mg
- IMNOVID capsule, hard 3 mg
- IMNOVID capsule, hard 4 mg
- NULOJIX powder for solution for infusion 250 mg
- ORENCIA PREFILLED SYRINGE solution for injection 125 mg/1 ml
- ORENCIA PREFILLED SYRINGE solution for injection 50 mg/0.4 ml
- ORENCIA PREFILLED SYRINGE solution for injection 87.5 mg/0.7 ml
- ORENCIA solution for infusion 250 mg
- REVLIMID capsule, hard 10 mg
- REVLIMID capsule, hard 15 mg
- REVLIMID capsule, hard 2.5 mg
- REVLIMID capsule, hard 20 mg
- REVLIMID capsule, hard 25 mg
- REVLIMID capsule, hard 5 mg
- REVLIMID capsule, hard 7.5 mg
- ZEPOSIA capsule, hard 0.23 mg - 0.46 mg
- ZEPOSIA capsule, hard 0.92 mg